Precision BioSciences, Inc. (DTIL) financial statements and ratios from SEC XBRL: revenue $34.26M (TTM), net margin -133.4%, revenue growth -50.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $34.26M |
| Net Margin | -133.4% |
| Revenue Growth (YoY) | -50.1% |
| EPS Growth (YoY) | -439.0% |
| FCF Growth (YoY) | 12.3% |
| Price / Book | 5.39 |
| Price / Sales | 11.26 |
| FCF Yield | -42.6% |
| Altman Z-Score | -2.72 (distress) |
| Sector P/E (Healthcare) | 21.7 |
DTIL overview · DTIL earnings · DTIL KPIs · DTIL investor relations · DTIL ownership · DTIL peers · DTIL filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.